Loading...

Medexus Pharmaceuticals Inc.

MEDXF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$2.92
$-0.08(-2.67%)
U.S. Market opens in 14h 20m

Medexus Pharmaceuticals Inc. (MEDXF) Stock Overview

Explore Medexus Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap94.1M
P/E Ratio-347.36
EPS (TTM)$-0.02
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$2.40
3 Months$1.80
1 Year Target$2.38

MEDXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Medexus Pharmaceuticals Inc. (MEDXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.92, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -347.36 and a market capitalization of 94.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.76%
5-Day Change
2.19%
1-Month Change
28.18%
3-Month Change
46.13%
6-Month Change
46.86%
Year-to-Date (YTD) Change
38.51%
1-Year Change
72.93%
3-Year Change
163.29%
5-Year Change
-49.96%
All-Time (Max) Change
-21.01%

Contact Information

https://www.medexus.com
877 633 3987
35 Nixon Road, Bolton, ON, L7E 1K1

Company Facts

82 Employees
IPO DateNov 27, 2017
CountryCA
Actively Trading

Frequently Asked Questions